FRLN Freeline Therapeutics Holdings plc ADRs

Freeline Therapeutics Holdings Plc operates as holding company whose subsidiaries provide biotechnology services. It develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Nathwani on April 3, 2020 and is headquartered in Stevenage, the United Kingdom. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

As of 12/02/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  
IPO date:  08/07/2020
Outstanding shares:  64,972,301
Average volume:  18,217
Market cap:   $39,828,021
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.37
PS ratio:   0.00
Return on equity:   -111.49%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy